{
  "abstract": "OBJECTIVES: To assess whether reinforced pneumococcal vaccination strategies improve immunogenicity in patients with ANCA-associated vasculitis (AAV) receiving rituximab. METHODS: PNEUMOVAS was a multicentre, open-label, randomized phase 2 superiority trial. Between February 2018 and May 2020, adults with newly diagnosed or relapsing granulomatosis with polyangiitis or microscopic polyangiitis scheduled for rituximab induction were randomized (1:1:1) to: standard vaccination (Arm A: one PCV13 dose at day 0 followed by PPV23 at month 5), reinforced regimen 1 (Arm B: two PCV13 doses at day 0 and two at day 7 followed by PPV23), or reinforced regimen 2 (Arm C: four PCV13 doses at day 0 followed by PPV23). The primary endpoint was the breadth of the ELISA antibody response at month 6, categorized as a response to 0-3, 4-6, 7-9, or 10-12 of 12 shared serotypes, and analyzed with an age-adjusted proportional odds model in the modified intention-to-treat population. RESULTS: Of 120 planned patients, 96 were randomized (30, 32, and 34 in Arms A, B, and C) and 95 were analyzed (median age 62 years; 47/95 [49.5%] male; median follow-up 17.9 months). At month 6, 1/30 (3.3%), 5/32 (15.6%), and 2/33 (6.1%) participants in Arms A, B, and C responded to 7-9 serotypes, and none to 10-12. Compared with the standard regimen, Arm B significantly improved the breadth of the response (proportional OR 4.14, 97.5% CI 1.08 to 15.88; p=0.018), whereas Arm C showed a non-significant trend (pOR 3.08, 97.5% CI 0.80 to 11.92). Reinforced schedules also improved opsonophagocytic activity for several serotypes. Vaccine responses declined over time in all groups. Vaccination was overall well tolerated, with no vaccine-related serious adverse events. CONCLUSIONS: In AAV patients receiving rituximab, reinforced pneumococcal vaccination strategies improved humoral immunogenicity compared with the standard regimen (ClinicalTrials.gov Identifier: NCT03069703).",
  "abstract_shown": true,
  "affiliations": [],
  "article_type": null,
  "arxiv": null,
  "author_total": 37,
  "authors": [
    {
      "name": "Benjamin Terrier"
    },
    {
      "name": "Laura Richert"
    },
    {
      "name": "Grégory Pugnet"
    },
    {
      "name": "Olivier Aumaître"
    },
    {
      "name": "Olivier Moranne"
    },
    {
      "name": "Noémie Huchet"
    },
    {
      "name": "Lucie Chevrier"
    },
    {
      "name": "Elisabeth Diot"
    },
    {
      "name": "Alexandre Karras"
    },
    {
      "name": "Fabrice Bonnet"
    },
    {
      "name": "Claire de Moreuil"
    },
    {
      "name": "Eric Hachulla"
    },
    {
      "name": "Thomas Le Gallou"
    },
    {
      "name": "Céline Lebas"
    },
    {
      "name": "Julien Campagne"
    },
    {
      "name": "Cédric Rafat"
    },
    {
      "name": "Maxime Samson"
    },
    {
      "name": "Jean-François Augusto"
    },
    {
      "name": "Grégoire Couvrat-Devergne"
    },
    {
      "name": "Cécile Janssen"
    },
    {
      "name": "Thierry Martin"
    },
    {
      "name": "Thomas Quemeneur"
    },
    {
      "name": "Pierre-Louis Carron"
    },
    {
      "name": "Cécile-Audrey Durel"
    },
    {
      "name": "Khalil El Karoui"
    },
    {
      "name": "Aurélie Grados"
    },
    {
      "name": "Mathieu Puyade"
    },
    {
      "name": "Marc Ruivard"
    },
    {
      "name": "Yurdagul Uzunhan"
    },
    {
      "name": "Jean-François Viallard"
    },
    {
      "name": "Xavier Puéchal"
    },
    {
      "name": "Loïc Guillevin"
    },
    {
      "name": "Corine Desaint"
    },
    {
      "name": "Hendy Abdoul"
    },
    {
      "name": "Carine Bellera"
    },
    {
      "name": "Frédéric Batteux"
    },
    {
      "name": "Odile Launay"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/5vvbdca6vcd65.bib",
  "cited_by": 0,
  "doi": "10.1016/j.cmi.2026.11.004",
  "fulltext_url": null,
  "id": "5vvbdca6vcd65",
  "issns": [
    "1198-743X",
    "1469-0691"
  ],
  "landing_url": "https://hal.science/hal-05864943v1",
  "language": "en",
  "licence": "CC-BY",
  "licence_label": "CC BY",
  "licence_source": "journal",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "hal",
      "0.sdv"
    ],
    [
      "hal",
      "1.sdv.imm"
    ],
    [
      "hal",
      "1.sdv.mhep"
    ],
    [
      "openalex",
      "2713|Pneumonia and Respiratory Infections"
    ]
  ],
  "openalex": "W7225755687",
  "pdf_url": null,
  "pmcid": null,
  "pmid": null,
  "published": "2026-11-15",
  "publisher": "Elsevier for the European Society of Clinical Microbiology and Infectious Diseases",
  "ris": "https://research.draconitic.com/paper/5vvbdca6vcd65.ris",
  "sources": [
    {
      "first_seen": "2026-11-15T12:20:48Z",
      "native_id": "hal-05864943",
      "source": "hal",
      "url": "https://hal.science/hal-05864943v1"
    }
  ],
  "subjects": [
    {
      "field": "biology",
      "origin": "hal:1.sdv.imm",
      "subfield": "immunology"
    },
    {
      "field": "medicine",
      "origin": "hal:1.sdv.mhep",
      "subfield": "general"
    }
  ],
  "title": "Reinforced strategies versus standard pneumococcal vaccination regimen in patients with ANCA-associated vasculitides receiving rituximab therapy: A Multicenter Randomized Controlled Trial",
  "title_text": "Reinforced strategies versus standard pneumococcal vaccination regimen in patients with ANCA-associated vasculitides receiving rituximab therapy: A Multicenter Randomized Controlled Trial",
  "type": "peer-reviewed",
  "updated_at": "2026-11-16T12:20:43Z",
  "url": "https://research.draconitic.com/paper/5vvbdca6vcd65",
  "venue": "Clinical Microbiology and Infection",
  "versions": []
}